Super Bowl ads are an opportunity for brands to put their work in front of more ...
A federal district judge dismissed a lawsuit challenging Medicare’s new drug pri...
Insurers are disappointed in the government's initial pitch for 2025 Medicare Ad...
South Asians are at greater risk of developing heart disease than white people, ...
A new study shows that in addition to preventing infections, the Ebola vaccine c...
By acquiring CymaBay, Gilead will gain a drug being developed for primary biliar...
Funding for developing mental health treatments derived from psychedelic drugs c...
In this morning's Pharmalittle roundup, we're reading about Moderna's RSV vaccin...
By one estimate, labor shortages have caused an 11% reduction in dental practice...
As allegations of data mishandling surge, universities and journals are playing ...
Oregon is at the forefront of the push for more scrutiny of deals that have priv...
Innovate UK has awarded £1m grant for a collaborative initiative called AI-VISIO...
The FDA granted breakthrough therapy status for J&J's nipocalimab for pregnant p...
Super Bowl LVIII saw Astellas run awareness for hot flashes and Pfizer touchdown...
The humanised monoclonal antibody DISC-3405 is under investigation in a Phase I ...
RadioMedix and Orano Med’s radioligand therapy AlphaMedix (lead-212-Dotamtate) i...
